Author: Morgan, Brittany S; Forte, Jordan E; Hargrove, Amanda E
Title: Insights into the development of chemical probes for RNA Document date: 2018_9_19
ID: wupre5uj_6
Snippet: The 116 chemical probes targeted 33 distinct RNA elements, including those from bacterial, fungal, human, or viral systems [ Figure 1 ]. Although some overlap between targets was observed, the small molecules probed a wider range of RNAs in cell culture than the multivalent ligands [ Figure 1A ]. The most common small molecule target was the HIV-1 Trans-activation response element (TAR) RNA, a well-studied and frequently screened RNA that binds t.....
Document: The 116 chemical probes targeted 33 distinct RNA elements, including those from bacterial, fungal, human, or viral systems [ Figure 1 ]. Although some overlap between targets was observed, the small molecules probed a wider range of RNAs in cell culture than the multivalent ligands [ Figure 1A ]. The most common small molecule target was the HIV-1 Trans-activation response element (TAR) RNA, a well-studied and frequently screened RNA that binds to the viral protein Tat (23) . Disruption of this interaction reduces viral production and represents an alternative strategy against HIV. Some of the first RNA-targeted chemical probes were developed for TAR RNA, including a tetraaminoquinozaline (28) and a 6-aminoquinolone (29, 30) with an EC 50 value of 16 M and an IC 50 value of 0.85 M, respectively, in chronically infected HIV cell models. On the other hand, only one bioactive small molecule was identified for a fungal target, specifically the Candida albicans LSU Group 1 Ribozyme (31). This essential ribozyme is a desirable antifungal target as it leads to failed ribosomal assembly when mutated and is absent in the human genome. Further, 10/75 small molecule chemical probes demonstrated efficacy in animal models, targeting seven unique RNA elements in bacterial and human systems. One recent example (19) targeted the G-quadruplex structure located in the 5 -untranslated region (UTR) of Human Vascular Endothelial Growth Factor (hVEGF) mRNA, an angiogenic growth factor involved in tumor progression. In a breast cancer mouse model, the small molecule showed antitumor efficacy similar to that of doxorubicin but with fewer indications of side effects.
Search related documents:
Co phrase search for related documents- alternative strategy and animal model efficacy: 1
- alternative strategy and cell culture: 1, 2, 3, 4, 5
- alternative strategy and cell model: 1
- alternative strategy and growth factor: 1
- alternative strategy and HIV alternative strategy: 1
- alternative strategy and mouse model: 1, 2, 3
- alternative strategy and recent example: 1
- alternative strategy and RNA target: 1
- alternative strategy and small molecule: 1, 2, 3, 4
- alternative strategy and viral production: 1, 2
- alternative strategy and viral protein: 1, 2, 3, 4, 5, 6, 7, 8
- alternative strategy and wide range: 1, 2, 3
- animal model and cancer mouse model: 1
- animal model and cell culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- animal model and cell culture rna: 1
- animal model and cell model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- animal model and growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- animal model and HIV cell model: 1
- animal model and mouse model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
Co phrase search for related documents, hyperlinks ordered by date